Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study
Open Access
- 25 February 2015
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 14 (5), 632-638
- https://doi.org/10.1016/j.jcf.2015.02.003
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health (U01-HL080310, UL1TR000423, P30 DK089507)
This publication has 20 references indexed in Scilit:
- Cystic Fibrosis: Management of HaemoptysisPaediatric Respiratory Reviews, 2012
- Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalating Study of Aerosolized Interferon Gamma‐1b in Patients With Mild to Moderate Cystic Fibrosis Lung DiseasePediatric Pulmonology, 2004
- Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosaJAMA, 2003
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisThe New England Journal of Medicine, 1999
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosisBMJ, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisThe New England Journal of Medicine, 1994
- Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.American Journal of Respiratory and Critical Care Medicine, 1994
- Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1994
- Pulmonary function between 6 and 18 years of agePediatric Pulmonology, 1993